Is telehealth’s ROI its post-pandemic saving grace? Cigna-MD Live’s latest study shows how the tech can cut on healthcare costs. We detail what’s behind telehealth’s power to slash costs for both providers and patients.
Candid announced plans to pull out of the direct-to-consumer space, shifting to B2B: The move by the oral care brand illustrates that D2C is not an automatic winner across all categories.
Peloton faces an uphill battle as it struggles with weak demand: New reports paint a picture of a company in crisis, making an acquisition attempt likely.
Lyra Health is eyeing the global telemental health benefits stage: On the back of its$235M haul and ICAS World acquisition, we look into why the mental health benefits market is booming, and how that’ll heat up competition for Lyra.
Turnkey telehealth solutions are becoming future of virtual care: Wheel scored $150 million to grow its plug-and-play telehealth platform. We detail who Wheel is and why it could succeed.
We unpack why new COVID-19 trackers like Walgreens’ and Verily’s return-to-work platform could see an uptick in adoption this year.
Technology. We detail iMediSync’s remote brain mapping helmet and a smart face mask developed by Northwestern University researchers.
Diagnostics giant takes a bigger bite of the digital health market: Quest Diagnostics is buying patient engagement firm Pack Health. We Look into why it’s making the move and how it could feed into a bigger digital health play.
Telehealth adoption has shot up over the past two years, with primary care as the most common use case in the US. Some 54% of US telehealth users had accessed this type of care virtually as of October.